>
Fa   |   Ar   |   En
   Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention  
   
نویسنده khazanie p. ,hellkamp a.s. ,fonarow g.c. ,bhatt d.l. ,masoudi f.a. ,anstrom k.j. ,heidenreich p.a. ,yancy c.w. ,curtis l.h. ,hernandez a.f. ,peterson e.d. ,al-khatib s.m.
منبع journal of the american heart association - 2015 - دوره : 4 - شماره : 8 - صفحه:e002061
چکیده    Background: implantable cardioverter-defibrillator (icd) therapy is associated with improved outcomes in patients with heart failure (hf),but whether this association holds among older patients with multiple comorbid illnesses and worse hf burden remains unclear.methods and results: using the national cardiovascular data registry's icd registry and the get with the guidelines-heart failure (gwtg-hf) registry linked with medicare claims,we examined outcomes associated with primary-prevention icd versus no icd among hf patients aged ≥65 years in clinical practice. we included patients with an ejection fraction ≤35% who received (icd registry) and who did not receive (gwtg-hf) an icd. compared with patients with an icd,patients in the non-icd group were older and more likely to be female and white. in matched cohorts,the 3-year adjusted mortality rate was lower in the icd group versus the non-icd group (46.7% versus 55.8%; adjusted hazard ratio [hr] 0.76; 95% ci 0.69 to 0.83). there was no associated difference in all-cause readmission (hr 0.99; 95% ci 0.92 to 1.08) but a lower risk of hf readmission (hr 0.88; 95% ci 0.80 to 0.97). when compared with no icd,icds were also associated with better survival in patients with ≤3 comorbidities (hr 0.77; 95% ci 0.69 to 0.87) and >3 comorbidities (hr 0.77; 95% ci 0.64 to 0.93) and in patients with no hospitalization for hf (hr 0.75; 95% ci 0.65 to 0.86) and at least 1 prior hf hospitalization (hr 0.69; 95% ci 0.58 to 0.82). in subgroup analyses,there were no interactions between icd and mortality risk for comorbidity burden (p=0.95) and for prior hf hospitalization (p=0.46).conclusion: among older hf patients,icds for primary prevention were associated with lower risk of mortality even among those with high comorbid illness burden and prior hf hospitalization. © 2015 the authors. published on behalf of the american heart association,inc.,by wiley blackwell.
کلیدواژه aging; defibrillation; heart failure; morbidity; mortality
آدرس duke clinical research institute,duke university school of medicine,durham,nc (p.k.,a.s.h.,k.j.a.,l.h.c.,a.f.h.,e.d.p.,s.m.a.k.) department of medicine,duke university school of medicine,durham,nc (p.k.,k.j.a.,l.h.c.,a.f.h.,e.d.p., S.M.A.K.), duke clinical research institute,duke university school of medicine,durham,nc (p.k.,a.s.h.,k.j.a.,l.h.c.,a.f.h.,e.d.p., S.M.A.K.), ahmanson-ucla cardiomyopathy center,los angeles, CA (G.C.F.), va boston healthcare system,brigham and women's hospital,harvard medical school,boston, MA (D.L.B.), university of colorado anschutz medical campus,aurora, CO (F.A.M.), duke clinical research institute,duke university school of medicine,durham,nc (p.k.,a.s.h.,k.j.a.,l.h.c.,a.f.h.,e.d.p.,s.m.a.k.) department of medicine,duke university school of medicine,durham,nc (p.k.,k.j.a.,l.h.c.,a.f.h.,e.d.p., S.M.A.K.), veterans affairs palo alto health care system,palo alto, CA (P.A.H.), northwestern university,chicago, IL (C.W.Y.), duke clinical research institute,duke university school of medicine,durham,nc (p.k.,a.s.h.,k.j.a.,l.h.c.,a.f.h.,e.d.p.,s.m.a.k.) department of medicine,duke university school of medicine,durham,nc (p.k.,k.j.a.,l.h.c.,a.f.h.,e.d.p., S.M.A.K.), duke clinical research institute,duke university school of medicine,durham,nc (p.k.,a.s.h.,k.j.a.,l.h.c.,a.f.h.,e.d.p.,s.m.a.k.) department of medicine,duke university school of medicine,durham,nc (p.k.,k.j.a.,l.h.c.,a.f.h.,e.d.p., S.M.A.K.), duke clinical research institute,duke university school of medicine,durham,nc (p.k.,a.s.h.,k.j.a.,l.h.c.,a.f.h.,e.d.p.,s.m.a.k.) department of medicine,duke university school of medicine,durham,nc (p.k.,k.j.a.,l.h.c.,a.f.h.,e.d.p., S.M.A.K.), duke clinical research institute,duke university school of medicine,durham,nc (p.k.,a.s.h.,k.j.a.,l.h.c.,a.f.h.,e.d.p.,s.m.a.k.) department of medicine,duke university school of medicine,durham,nc (p.k.,k.j.a.,l.h.c.,a.f.h.,e.d.p., S.M.A.K.)
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved